The states are coming for AI therapy bots
It's clear that therapy chatbots can benefit people — but states may have good reason to intervene anyway
Read more
My dinner with Altman
In a wide-ranging conversation with reporters, OpenAI's CEO discusses the GPT-5 backlash, the AI bubble, and whether he would build a social network
Grok is on the rocks
Trailing ChatGPT on the charts, and suspended by its own maker, Elon Musk asks: is this Apple's fault?
Three big lessons from the GPT-5 backlash
In which an industry obsessed with benchmarks and evals finds that its products are being used by real people
GPT-5 is alive
It's big news for free users of ChatGPT, but AGI remains elusive. PLUS: one AI safety idea other labs should borrow